Article Versions Notes

Dong W, Wang Y, Li H, Ma H, Gong Y, Luo G, Gao X. Integration of Pseudotargeted Metabolomics and Microbiomics Reveals That Hugan Tablets Ameliorate NASH with Liver Fibrosis in Mice by Modulating Bile Acid Metabolism via the Gut Microbiome. Metabolites. 2025; 15(7):433. https://doi.org/10.3390/metabo15070433

Dong, Wenran, Ying Wang, Huajinzi Li, Huilin Ma, Yingxi Gong, Gan Luo, and Xiaoyan Gao. 2025. "Integration of Pseudotargeted Metabolomics and Microbiomics Reveals That Hugan Tablets Ameliorate NASH with Liver Fibrosis in Mice by Modulating Bile Acid Metabolism via the Gut Microbiome" Metabolites 15, no. 7: 433. https://doi.org/10.3390/metabo15070433

Dong, W., Wang, Y., Li, H., Ma, H., Gong, Y., Luo, G., & Gao, X. (2025). Integration of Pseudotargeted Metabolomics and Microbiomics Reveals That Hugan Tablets Ameliorate NASH with Liver Fibrosis in Mice by Modulating Bile Acid Metabolism via the Gut Microbiome. Metabolites, 15(7), 433. https://doi.org/10.3390/metabo15070433